mSTING agonist; selective for mouse STING over human STING. Induces IFN-β
and cytokine production from bone marrow-derived dendritic cells. Causes tumor regression following intratumoral administration in mouse tumor models. Induces an adaptive immune response to reduce systemic tumor growth and provides immunological memory against autologous tumor re-challenge. Also antiviral.
Soluble to 20 mM in DMSO
Store at +4°C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-β-mediated antiviral activity in vitro and in vivo.
Shirey et al.
Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 220.127.116.11) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development.
Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity.
Corrales et al.
Cell Rep., 2015;11:1018